US Stock MarketDetailed Quotes

TPB Turning Point Brands

Watchlist
  • 70.300
  • +1.300+1.88%
Close Feb 28 16:00 ET
  • 70.300
  • 0.0000.00%
Post 20:01 ET
1.25BMarket Cap28.23P/E (TTM)

Turning Point Brands Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Turning Point Brands Q4 2024 Estimates Date

Currency：USDMar 6, 2025

Estimate YoY
Revenue
95.56M
-1.61%
EPS
0.69
+30.66%
Analyst Rating
Strong Buy

Feb 28, 2025

Turning Point Brands Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 95.108M--
Mar 6, 20252024/Q4-- / 95.561M--
Nov 7, 20242024/Q3105.617M / 100.713M--
Aug 1, 20242024/Q2108.512M / 96.141M--
May 2, 20242024/Q197.058M / 90.659M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 95.108M--
Mar 6, 20252024/Q4-- / 95.561M--
Nov 7, 20242024/Q3105.617M / 100.713M--
Aug 1, 20242024/Q2108.512M / 96.141M--
May 2, 20242024/Q197.058M / 90.659M--

Unlock Free Earnings Estimates

Turning Point Brands Earnings Reports

  • Turning Point Brands | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 22:32 ET

  • Turning Point Brands | 8-K: Turning Point Brands Announces Third Quarter 2024 Results

    Nov 7, 2024 08:18 ET

  • Turning Point Brands | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 16:31 ET

  • Turning Point Brands | 8-K: Turning Point Brands Announces Second Quarter 2024 Results

    Aug 1, 2024 09:11 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data